Treatment of prostate cancer: therapeutic potential of targeted immunotherapy with APC8015

Robert A BokDepartment of Radiology, University of California at San FranciscoSan Francisco, CA, USACorrespondence[email protected]

Pages 79-85 | Published online: 08 Feb 2008

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

BurchPABreenJKBucknerJCPriming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancerClin Cancer Res2000621758210873066
PubMed Web of Science ®Google Scholar
BurchPACroghanGAGastineauDAImmunotherapy (APC8015, Provenge®) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate cancer: a phase 2 trialThe Prostate200460107204
Web of Science ®Google Scholar
ColeyWBThe treatment of malignant tumors by repeated inoculations of erysipelas: With a report of ten original casesAm J Med Sci1893105487
Google Scholar
Curiel-LewandrowskiCMahnkeKLabeurMTransfection of immature murine bone marrow-derived dendritic cells with the granulocyte-macrophage colony-stimulating factor gene potently enhances their in vivo antigen-presenting capacityJ Immunol19991631748310384114
PubMed Web of Science ®Google Scholar
FongLBrockstedtDBenikeCDendritic cell-based xenoantigen vaccination for prostate cancer immunotherapyJ Immunol20011677150611739538
PubMed Web of Science ®Google Scholar
HamawyKJLibertinoJFrohlichMImproved survival with Sipuleucel-T (Apc8015) in men with advanced prostate cancer2006American Urological Assoc 75th Annual Meeting
Google Scholar
HartDNDendritic cells: unique leukocyte populations which control the primary immune responseBlood1997903245879345009
PubMed Web of Science ®Google Scholar
HurwitzAAFosterBAKwonEDCombination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockadeCancer Res2000602444810811122
PubMed Web of Science ®Google Scholar
HsuFJBenikeCFagnoniFVaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cellsNat Med199625288564842
PubMed Web of Science ®Google Scholar
JemalASiegelRWardECancer StatisticsCA Cancer J Clin2006561063016514137
PubMed Web of Science ®Google Scholar
JemalASiegelRWardECancer statisticsCA Cancer J Clin200757436617237035
PubMed Web of Science ®Google Scholar
KleinCBuelerHMulliganRCComparative analysis of genetically modified dendritic cells and tumor cells as therapeutic cancer vaccinesJ Exp Med2000191169970810811863
PubMed Web of Science ®Google Scholar
MercaderMBodnerBKMoserMTT cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancerProc Natl Acad Sci USA200198145657011734652
PubMed Web of Science ®Google Scholar
NakamuraMIwahashiMNakamoriMDendritic cells genetically engineered to simultaneously express endogenous tumor antigen and granulocyte macrophage colony-stimulating factor elicit potent therapeutic antitumor immunityClin Cancer Res200282742912171908
PubMed Web of Science ®Google Scholar
OyamaTRanSIshidaTVascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kB activation in hemopoietic progenitor cellsJ Immunol19981601224329570538
PubMed Web of Science ®Google Scholar
QuezadaSAPeggsKSCurranMACTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cellsJ Clin Invest200611619354516778987
PubMed Web of Science ®Google Scholar
RiniBIFongLWeinbergVClinical and immunological characteristics of patients with serologic progression of prostate cancer achieving long-term disease control with granulocyte-macrophage colony-stimulating factorJ Urology2006175208791
PubMed Web of Science ®Google Scholar
RosenbergSAProgress in the development of immunotherapy for the treatment of patients with cancerJ Intern Med20012504627511902815
PubMed Web of Science ®Google Scholar
RossRWKantoffPWHormone-refractory prostate cancer: choosing the appropriate treatment optionOncology (Williston Park)2007211859317396482
PubMed Web of Science ®Google Scholar
SaikaTSatohTKusakaNRoute of administration influences the antitumor effects of bone marrow-derived dendritic cells engineered to produce interleukin-12 in a metastatic mouse prostate cancer modelCancer Gene Therapy2004113172415044961
PubMed Web of Science ®Google Scholar
SallustoFLanzavecchiaAEfficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factorJ Exp Med19941791109188145033
PubMed Web of Science ®Google Scholar
SmallEJFratesiPReeseDMImmunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cellsJ Clin Oncol200018389490311099318
PubMed Web of Science ®Google Scholar
SmallEJSchellhammerPFHiganoCSPlacebo-controlled phase III trial of immunologic therapy with Sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancerJ Clin Oncol20062430899416809734
PubMed Web of Science ®Google Scholar
SpitlerLEGrossbardMLErnstoffMSAdjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factorJ Clin Oncol20001816142110764421
PubMed Web of Science ®Google Scholar
SrivastavaPKTherapeutic cancer vaccinesCurr Opin Immunol200618201516464565
PubMed Web of Science ®Google Scholar
SteinmannRMCohnZAIdentification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distributionJ Exp Med19731371142624573839
PubMed Web of Science ®Google Scholar
TannockIFde WitRBerryWRDocetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancerN Engl J Med200435115021215470213
PubMed Web of Science ®Google Scholar
WilkinsonRKassianosAJSwindlePNumerical and functional assessment of blood dendritic cells in prostate cancer patientsThe Prostate2006661809216173035
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Treatment of prostate cancer: therapeutic potential of targeted immunotherapy with APC8015

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Treatment of prostate cancer: therapeutic potential of targeted immunotherapy with APC8015

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date